MD3284F1 - Method of treatment of allergic rhinitis, atopic dermatitis and chronic recurrent urticaria - Google Patents

Method of treatment of allergic rhinitis, atopic dermatitis and chronic recurrent urticaria

Info

Publication number
MD3284F1
MD3284F1 MDA20060148A MD20060148A MD3284F1 MD 3284 F1 MD3284 F1 MD 3284F1 MD A20060148 A MDA20060148 A MD A20060148A MD 20060148 A MD20060148 A MD 20060148A MD 3284 F1 MD3284 F1 MD 3284F1
Authority
MD
Moldova
Prior art keywords
treatment
atopic dermatitis
allergic rhinitis
chronic recurrent
urticaria
Prior art date
Application number
MDA20060148A
Other languages
Romanian (ro)
Other versions
MD3284G2 (en
Inventor
Vera Onu
Aurel GIRBEA
Ala DERBENTEVA
Ion Ababii
Vladimir Popa
Original Assignee
Aurel GIRBEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurel GIRBEA filed Critical Aurel GIRBEA
Priority to MDA20060148A priority Critical patent/MD3284G2/en
Publication of MD3284F1 publication Critical patent/MD3284F1/en
Publication of MD3284G2 publication Critical patent/MD3284G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Inventia se refera la medicina, si anume la terapie, dermatologie, otorinolaringologie si alergologie. Metoda de tratament al rinitei alergice, dermatitei atopice si urticariei cronice recidivante, conform inventiei, consta in aceea ca se efectueazaelectroforeza endonazala cu solutie de cetirizina1% o data in zi timp de 12…15 zile si se administreaza substante antihistaminice H1 de prima generatie in doza terapeutica in decursul primelor 5…7 zile de tratament per os pe noapte.The invention relates to medicine, namely to therapy, dermatology, otolaryngology and allergy. The method of treatment of allergic rhinitis, atopic dermatitis and chronic relapsing urticaria, according to the invention, consists of endonazal electrophoresis with cetirizine solution1% once daily for 12 ... 15 days and first-generation antihistamine H1 is administered in dose therapeutic during the first 5 ... 7 days of treatment per bone per night.

MDA20060148A 2006-05-30 2006-05-30 Method of treatment of allergic rhinitis, atopic dermatitis and chronic recurrent urticaria MD3284G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20060148A MD3284G2 (en) 2006-05-30 2006-05-30 Method of treatment of allergic rhinitis, atopic dermatitis and chronic recurrent urticaria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20060148A MD3284G2 (en) 2006-05-30 2006-05-30 Method of treatment of allergic rhinitis, atopic dermatitis and chronic recurrent urticaria

Publications (2)

Publication Number Publication Date
MD3284F1 true MD3284F1 (en) 2007-04-30
MD3284G2 MD3284G2 (en) 2007-11-30

Family

ID=38164582

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20060148A MD3284G2 (en) 2006-05-30 2006-05-30 Method of treatment of allergic rhinitis, atopic dermatitis and chronic recurrent urticaria

Country Status (1)

Country Link
MD (1) MD3284G2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2494774C1 (en) * 2012-09-12 2013-10-10 Общество с ограниченной ответственностью "КОЛЕТЕКС" Method of treating allergic rhinitis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2494774C1 (en) * 2012-09-12 2013-10-10 Общество с ограниченной ответственностью "КОЛЕТЕКС" Method of treating allergic rhinitis

Also Published As

Publication number Publication date
MD3284G2 (en) 2007-11-30

Similar Documents

Publication Publication Date Title
DK1551409T3 (en) Use of the quinazoline derivative ZD6474 in combination with gemcitabine and possibly ionizing radiation in the treatment of cancer
WO2007143231A3 (en) Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists
NO20060307L (en) Use of the quinoazoline derivative ZD6474 in combination with platinum compounds and possibly ionizing radiation in the treatment of diseases associated with angiogenesis and / or ocular vascular permeability
DK1970059T3 (en) Calcium dobesilate drug for the treatment and prophylaxis of tendon disorders
NO20050851L (en) Caspase Inhibitors and Uses thereof
EA200900211A1 (en) SUBSTITUTED IMIDAZOLONE DERIVATIVES, THEIR RECEIVING AND APPLICATION
DE60331537D1 (en) COMBINATIONS FOR THE TREATMENT OF MULTIPLE MYELOMA
EA200971053A1 (en) METHODS OF TREATMENT OF THE LEAD ULCERS
WO2006130679A3 (en) Composition and method for the treatment of allergic rhinitis
WO2009074827A3 (en) Combination comprising a mek inhibitor and an aurora kinase inhibitor
TW200740808A (en) Inhibiteurs de proteines kinases
CY1107352T1 (en) PRE-OPERATIVE THERAPEUTIC PURPOSE
EP2473037A4 (en) Method of treatment of neurodegenerative or neuro-muscular degenerative diseases and therapeutic agent to treat the same
DK1784173T3 (en) Pharmaceutical composition for the prevention and treatment of metabolic bone disorders containing alpha-arylmethoxyacrylate derivatives
DE602006011959D1 (en) NA +, K + -ATPASE EXPRESSION IN ZERVIX DYSPLASIA AND CANCER
MX2008002456A (en) Use of ambroxol for the treatment of rhinovirus infections.
NO20056170L (en) Cancer combination therapy comprising AZD2171 or ZD1839
BRPI0411324A (en) pharmaceutical compositions and methods of treating histamine-mediated response in patients
NO20064755L (en) combination therapy
MA39447B1 (en) Pirlindole or its pharmaceutically acceptable salts for use in medicine
MD3284F1 (en) Method of treatment of allergic rhinitis, atopic dermatitis and chronic recurrent urticaria
MA39448B1 (en) (r) -pirlindole and its pharmaceutically acceptable salts for medical use
UA109359C2 (en) TREATMENT OF SKIN DISEASES AND STATES
DK1732551T3 (en) Perhexilin for the treatment of chronic heart failure
NO20073610L (en) Newly substituted thiophenpyrimidinone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees